Dbx, a divergent homeobox gene, is expressed in a regionally restricted pattern in the developing mouse central nervous system (CNS). In order to understand its spatial regulation, we have isolated a &-regulatory region using a reporter gene analytical approach in transgenic mice. A 5.7 kb DNA fragment that contains the transcriptional start site of the Dbx gene is sufficient to direct the expression of the transgene to various domains of the CNS in a temporally regulated fashion. The transgene expression can be detected between 9.5 and 15.5 days post coitum in embryos in the fore-, mid-and hindbrain and spinal cord in regions where the endogenous gene is expressed. Additionally, transgene expression can also be detected in the oculomotor nerve (cranial nerve III). The expression of the transgene closely resembles that of the Dbx gene with minor, but interesting differences. These results suggest that major c&acting elements reside within a 5.7 kb DNA fragment located 5' of the Dbx gene. Further deletion analysis shows that at least two independ: ently regulated elements are present within this DNA fragment: an element that directs expression to the brain and spinal cord and a second element that directs expression to the oculomotor nerve.
Introduction
The molecular basis of brain patterning has been advanced by the discovery of multiple families of transcription factors, including members of homeobox gene family (De Robertis, 1994) . The major family of the homeobox genes, the Hox genes, are implicated in the developmental control of the posterior neural tube up to the midbrain/ hindbrain junction. Mutational analyses have demonstrated that abnormal Hox gene expression can result in homeotic transformations and malformations, showing that homeobox genes are involved in the specification of regional identities during embryogenesis (Krumlauf, 1994) . In recent years, a number of divergent homeobox genes have been identified and many of these show restricted expression in the brain (Porteus et al., 1991; Price et al., 1991 Price et al., , 1992 Simeone et al., 1992a Simeone et al., ,b, 1994 Puelles and Rubenstein, 1993; Bulfone et al., 1993 Bulfone et al., , 1995 reviewed in Rubenstein and Puelles, 1994) . To study forebrain patterning, we have isolated a divergent homeobox gene, Dbx, from the embryonic telencephalon and characterized its expression. Dbx is expressed during neurogenesis in restricted regions of the fore-, mid-and hindbrain and spinal cord. In the forebrain, Dbx is expressed in the lateral telencephalon and hypothalamus (Lu et al., 1992 (Lu et al., , 1994 .
The expression of homeobox genes is regulated primarily at the level of transcription (Krumlauf, 1994) . Factors that govern the spatial expression of Dbx may provide valuable insight into the various signalling pathways that control brain patterning. A critical first step in identifying such factors is the detection and characterization of cis-regulatory elements that direct the expression of Dbx during embryogenesis.
Here we report on the identification of regulatory regions required for Dbx expression in the central nervous system (CNS) employing reporter gene analysis in transgenic mice.
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Results

Regulatory regions of Dbx are located within 5.7 kb S'flanking sequences
The genomic structure of Dbx and various reporter constructs are depicted in Fig. 1 . The basal promoter of Dbx is shown in Fig. la . The transcription start site of the Dbx gene is located 133 nucleotides 5' from the first codon (Lu et al., 1994) . Dbx has typical TATAA and CCAAT sequences located at positions -30 and -140, respectively (Fig. la) . To identify the regulatory elements of the Dbx gene, we isolated a 5.7 kb Kpn I-Bst E II upstream genomic DNA fragment and used it to direct the expression of a #I-galactosidase @-gal) reporter gene. This construct, 5.7 kb-Lac Z, contained the basal promoter plus 31 nucleotides of the 5' untranslated region of the Dbx gene upstream of &gal (Fig. lb) . The 5.7 kb-Lac Z construct was injected into one-cell embryos and its expression was analyzed in founder generation embryos at 11.5 days post coitum (pc.). We obtained seven transgenie embryos displaying /?-gal activity reproducibly in the brain and spinal cord resembling the endogenous Dbx gene expression pattern, indicating that the upstream sequence of the Dbx gene contains regulatory elements sufficient for normal expression. We established permanent transgenic lines to analyze the expression pattern of the transgene in detail. Two founder lines showed identical expression patterns of p-gal staining at all stages of development and were used interchangeably in further studies.
Typically, the expression of the transgene is first detected in the embryonic diencephalon and mesencephalon at 9.5 days p.c. (Fig. 2a) . B-Gal expression begins to appear in regions of the telen-and myelencephalons, in the nuclei of the oculomotor nerve (cranial nerve III), and in the spinal cord between 9.5 and 9.7 days p.c. (Fig. 2b) . The expression pattern of the transgene persists in these regions at 10.5 days p.c. /I-Gal activity could be detected in the lateral telencephalon and dorsal diencephalon of the forebrain in whole mount embryos (Fig. 2~) . The expression in the hypothalamus could be detected in embryo sections, although it could not be readily visualized in whole mount embryos because of its internal location (data not shown). In regions of the CNS posterior to the forebrain, B-gal expressing cells could be detected in the mesencephalon, a region with the strongest transgene expression. In the myelencephalon and spinal cord, the transgene is expressed in two bilaterally symmetrical columns of cells. B-Gal expression is also detected in the nuclei of the oculomotor nerve (Fig. 2~) . At 11.5 days p.c., the overall expression pattern of the transgene is similar to that of 10.5 days p.c. embryos. /I-Gal expression is detected in the fore-, mid-and hindbrain and spinal cord. Axons extending from oculomotor nuclei at this stage are positive for the expression of /-?-gal (Figs. 2d and 5a).
Transgenic
embryos were sectioned for a detailed analysis. /I-Gal staining is observed in the mesencephalon in horizontally, serially sectioned 11.5 days pc. embryos (Fig. 3a) . B-Gal-positive cells are distributed throughout the entire dorsal wall of the mesencephalon with the exception of the midlines. Positive cells are unevenly distributed. The number of /I-gal-positive cells is greater in areas close to the pial surface than those neighboring the ventricular surface (Fig. 3a) . In contrast, endogenous Dbx transcripts are distributed evenly throughout the entire region as suggested by in situ hybridization analysis. In sections at more caudal levels, b-gal expression could be detected in the dorsal diencephalon and hypothalamus (Fig. 3b,c) , where the Dbx transcripts were detected at this stage. B-Gal expression was also detected in the telencephalon of 11.5 days p.c. embryos, whereas Dbx transcripts were detected only at 12.5 days p.c. (Fig. 3c ) (Lu et al., 1992) . B-Gal expression in the telencephalon is stronger in the region ventral to the basal ganglia as compared to the lateral telencephalon (Fig. 3~ ). In the spinal cord, /?-gal-expressing cells are distributed in both the ventricular and intermediate zones. P-Gal-positive cells in the ventricular zone are located immediately ventral to the sulcus limitans, while cells outside the ventricular zone were distributed dorsoventrally along the junction of the ventricular and intermediate zones (Fig. 3d) . In the thoracic spinal cord, the majority of B-gal-positive cells are located dorsal to the sulcus limitans and some reached as far as the roof plate. This group of dorsally located cells can also be seen in the whole mount embryos ( Fig. 2d ; also in Fig. 2b at an earlier stage). In the lumbar spinal cord, more B-gal-positive cells are located ventral to the sulcus limitans in comparison to the cervical spinal cord (Fig. 3d) , while in the sacral spinal cord /3-gal-positive cells are almost exclusively found ventral to the sulcus limitans outside of the ventricular zone. Some of the ventrally located &gal-positive cells extended to the floor plate and ventral horns (data not shown). Only a small number of /?-gal-positive cells are found in the ventricular zone at any level, and these are invariably located immediately ventral to the sulcus limitans.
At 12.5 days p.c., expression of the transgene persists in regions of the telen-, dien-, mesen-and myelencephalon and spinal cord (Fig. 2e) . Horizontal embryonic sections at this stage showed a stronger B-gal staining compared to 11.5 days p.c. The entire wall of the dorsal mesencephalon was strongly stained except at the midlines (Fig. 3e) . In the diencephalon, /I-gal expression was detected in the dorsal diencephalon and hypothalamus (Figs. 2e and 3f) . Expression in the dorsal diencephalon was strong, although regions with fewer P-gal-positive cells could be seen near the third ventricle. This expression domain has a sharp ventral boundary (Fig. 3f) ; however, cells near the pial surface did not appear to respect this boundary. They formed a line of cells that extended ventrally from the diencephalon to the mes- encephalon ( Fig. 3f) . B-Gal expression is also detected in the medial and ventro-lateral telencephalon at this stage (Fig. 3g) . The dorsal boundary of this expression is approximately at the level of the basal ganglia. In some sections, the expression domain of the transgene is contiguous between the telencephalon and the diencephalic thalamus (Fig. 3h) . It is not clear whether the expression of the transgene in the thalamus is local or due to the migration of the B-gal-expressing cells from the telencephalon to the diencephalon.
/?-Gal expression at 12.5 days p.c. is more disbursed when compared to the distribution of endogenous Dbx transcripts. /?-Gal-positive cells are more widely distributed in the spinal cord. The majority of the expressing cells are in the marginal zone, ranging from the dorsal roof to the floor plate and also in the ventral horn (Fig. 3i) . A difference in the distribution of j% gal-positive cells at different levels of the spinal cord is also observed at this stage, similar to that observed at 11.5 days p.c. (data not shown). A few P-gal-expressing cells are always detected in the ventricular zone. These cells were located immediately ventral to the sulcus limitans in the same regions where endogenous Dbx transcripts are detected. B-Gal expression begins to diminish after 13.5 days p.c. The expression could still be seen in the mesencephalon and dorsal diencephalon, while weak expression was observed in the telencephalon and hypothalamus (Fig. 2f') . No expression of the transgene is detected in the spinal cord. At 15.5 and 16.5 days p.c., B-gal activity was detected in the primitive cerebellum and isolated regions of the diencephalon such as the geniculate and mammilary nuclei (data not shown). In summary, the expression pattern of the transgene is largely consistent with that of the endogenous Dbx gene except for a few differences that will be discussed below.
Separate regulatory elements direct the expression of the reporter gene in the oculomotor nerve and brain
The experiments described above show that the major c&regulatory elements of the Dbx gene are situated in the 5.7 kb genomic DNA fragment upstream of the translational start site. Since the 5.7 kb DNA fragment directs expression of the reporter gene in multiple domains ranging from the forebrain to the spinal cord, it was of interest to determine if separate elements are responsible for expression in different regions of the CNS. We carried out deletion analysis to address this question.
First, we injected the 1.6 kb-Lac Z construct that contains a 1.6 kb DNA fragment immediately upstream of the translational start site (Fig. lb) . This construct contains the canonical TATAA and CCAAT box sequences (Fig.  la) . When analyzed at 11.5 days p.c., six founder transgenie embryos showed B-gal expression. However, each of the embryos exhibited an expression pattern which was unique to the embryo and unrelated to that of the Dbx gene (data not shown). This suggested that the proximal 1.6 kb fragment was not capable of directing the reporter gene expression to any specific region and was likely to be influenced by local enhancers situated at its site of integration.
Next, we lengthened the construct by an additional 1.1 kb upstream DNA segment. The resulting 2.7 kbLacZ construct (Fig. lb) was analyzed for expression in transgenic embryos at 11.5 days p.c. In all of the 11 /Igal-positive founder embryos, B-gal expression was observed in the nuclei and axons of the oculomotor nerve. A stable transgenic line was established to study temporal expression. Expression was first observed at 9.5 days p.c. in the nuclei of the oculomotor nerve and in both nuclei and axons at 10.5 days p.c. (Fig. 4a,b) . Expression persisted at 11.5 days p.c. and was last observed at 12.5 days p.c. (Figs. 4c,d and 5b) . These results map the oculomotor c&regulatory elements within the distal 1.1 kb of the 2.7 kb DNA fragment.
Finally, we tested the distal 3 kb DNA fragment for enhancer activity in transgenic embryos. The DNA fragment was ligated upstream of a heterologous promoter, hsp68, driving the /I-gal gene (3 kb-hsplac Z in Fig. lb) . The expression pattern of this transgene in six P-galpositive founder embryos was similar to that of the 5.7 kb-Lac Z transgene founder generation embryos, except that the expression in the oculomotor nerve was absent (data not shown). Two permanent transgenic lines were established using a similar construct, 3.5 kb-hsplac Z (Fig. lb) , and one of them was used for analysis of the temporal expression of the transgene. The spatio-temporal expression of embryos from this transgenic line closely resembled the 5.7 kb-Lac Z; however, no expression in the oculomotor nerve was detected at any stage . This indicates that the regulatory elements controlling the expression in the fore-, mid-and hindbrain and the spinal cord resides in the distal 3 kb DNA fragment. To determine if this enhancer could act in an orientation-independent manner, the distal 3 kb fragment was cloned in the reversed orientation in the hspLacZ vector (3 kb-rhspLacZ in Fig. lb) , and its expression in transgenie embryos was analyzed. Eight B-gal-positive founder generation embryos assayed for reporter gene activity at 11.5 days p.c. showed a pattern of expression in the CNS indistinguishable from that generated from the 3 kbhsplacZ or 3.5 kb-hsplacZ construct (Fig. 4h) . Since the distal 3 kb of the 5.7 kb DNA directs p-gal expression in the brain and spinal cord, we did a further deletion analysis of this DNA fragment. The distal 2 kb of the 3 kb (2 kb-hsplac Z, Fig. lb ) generated similar expression as the 3 kb fragment. Further deletion of the 2 kb DNA has given us inconsistent transgene expression patterns with increasing ectopic expression, indicating shorter Dbx DNA fragments may lack independent regulatory elements and are easily influenced by their sites of integration (data not shown).
Discussion
Major cis-regulatory elements of the Dbx gene are contained within the S'flanking region
The B-gal expression pattern generated by the 5.7 kb Dbx upstream sequence closely resembles the endogenous Dbx expression pattern both temporally and spatially. Both the p-gal transgene and the Dbx gene are expressed from 9.5 to 15.5 days p.c. B-Gal expression was detected in all the regions where the endogenous gene is expressed. There are four discrepancies between the /I-gal transgene and the endogenous gene expression patterns. First, the initiation of p-gal transgene expression in the diencephalon and spinal cord occur slightly later than that of the endogenous Dbx gene. Endogenous Dbx expression is detected at 9.5 days p.c_ in these regions (Lu et al., 1992) , while /I-gal expression is detected at approximately 9.7 days p.c. (Fig. 2a,b) . Second, the expression of B-gal is detected in the telencephalon from 9.7 to 13.5 days p.c. (Fig. 2b-f) , while Dbx is only detected at 12.5 days p.c. by in situ hybridization (Lu et al., 1992 (Lu et al., , 1994 . Third, some /?-gal-positive cells in transgenic embryos are located in regions that are different from but adjacent to those where the Dbx transcripts are detected. For example, the expression of /?-gal was detected in the marginal zone of the hypothalamus at 12.5 days pc. (Fig.  3h) , while the endogenous Dbx gene was only detected in the ventricular zone (Lu et al., 1992 ). Although we believe the 5.7 kb-Lac Z reproduces the expression of the endogenous gene and the difference between the two is likely due to the difference in detection methods, we cannot exclude the possibility that there are some regulatory elements outside the 5.7 kb Dbx DNA that are responsible for the fine-tuning of Dbx expression. A fourth and significant difference between the expression patterns of Dbx and reporter genes was expression in the oculomotor nerve. /?-Gal expression was detected in the oculomotor nerve from 9.5 to 12.5 days p.c. while no Dbx expression was detected by in situ hybridization.
The results of in situ hybridization with Dbx antisense RNA probe was closely re-examined and no signal could be distinguished from the background in regions corresponding to the oculomotor nuclei. This discrepancy may have resulted from the absence of negative regulatory elements in the 5.7 kb Dbx genomic DNA fragment, although the overall expression pattern generated by this DNA fragment is entirely consistent with that of the endogenous Dbx gene. Another possibility is that the difference between the expression patterns can be attributed to detection methods. Since the nuclei of the oculomotor nerve contain only a small number of cells, in situ hybridization signals in the nuclei may not be distinguished from background.
The Dbx gene exhibits a complex expression pattern during embryogenesis.
The expression domains are numerous and range from the forebrain to the spinal cord. Our deletion analysis in transgenic mice with various Dbx-Lac Z constructs has shown that the distal 3 kb of the 5.7 kb Dbx regulatory sequence directs the expression of the transgene to the brain and spinal cord, while the proximal 2.7 kb fragment controls expression in the oculomotor nerve. This indicates that the Dbx upstream sequence contains at least two independent regulatory elements. Expression in the telencephalon, diencephalon, mesencephalon, myelencephalon and spinal cord is regulated by the distal 3 kb of the 5.7 kb fragment and this regulatory sequence acts in an orientation-independent enhancer. The expression in the oculomotor nerve is 200 S. regulated through the proximal 2.7 kb of the 5.7 kb fragment. These results suggest that Dbx may be regulated by combinations of transcriptional factors expressing in different regions of the CNS.
B-Gal as a marker for tracing cell migration in the central nervous system
As discussed above, the expression of /?-gal in transgenie embryos was more disbursed than that of the endogenous Dbx transcripts as determined by in situ hybridization. For example, the endogenous Dbx transcripts were only detected in the ventricular zone in the hypothalamus of the diencephalon, myelencephalon and spinal cord, while B-gal-expressing cells were distributed from the ventricular zone to the marginal zone in these regions (Fig. 3c,d ,h,i). This could result from the incompleteness of the regulatory elements in the Dbx DNA fragment we analyzed. However, we favor the explanation that the more disbursed distribution of /?-gal-expressing cells resulted from the migration of these cells. Since the /?-gal protein is likely to have a longer half life than the Dbx transcripts, B-gal may persist in expressing cells after these cells cease to express the messenger RNA of Dbx or B-gal. At the same time, cells actively migrate from ventricular zones towards their final locations. As a result, expressing cells would be detected outside the regions where the endogenous Dbx transcripts were detected. We favor this explanation for the following reasons. (1) The &gal-expressing cells outside Dbx-expressing domains are always adjacent to those within the Dbx-expressing domains. (2) The expressing cells often appear in the marginal zone outside the ventricular zone where Dbx and B-gal are expressed (Fig. 3c,d ,f-i, and data not shown). This is in agreement with an established neuronal migration from the ventricular to marginal zones. (3) The /l-galexpressing cells are often elongated in shape and their orientations are parallel to the proposed cell migration path (Fig. 3a,c,d ). The latter is a cytological characteristic of migratory cells (Rakic, 1972) (Fig. 3d,i) . Some of the cells are in the ventral horn, where motor neurons reside (Fig. 3i) . Since all cells are generated in the ventricular zone, these B-gal-positive cells outside the ventricular zone are likely to have originated from the same B-gal-positive region within the ventricular zone. Studies of cell migration in chick spinal cord using recombinant retroviruses have indicated that cells migrate radially from the ventricular zone, then a subpopulation migrates circumferentially in relation to the surface of the spinal cord (Leber et al., 1990; Leber and Sanes, 1995) . If cell migration in the mouse spinal cord follows a similar route, the offspring of cells that express the Dbx transcripts would be widely distributed in the spinal cord following migration from the ventricular zone. In the diencephalon and telencephalon, the expression of P-gal is detected in a domain in the thalamus which is contiguous to the expression domain in the telencephalon, while the expression of endogenous Dbx transcripts is not detected in this region of the thalamus (Fig. 3h) . This situation can also be explained by the migration of B-gal-expressing cells from the telencephalon to the diencephalon.
Interestingly, cell migration following a similar route has been observed in human fetuses (Rakic and Sidman, 1969) . process with increasing control and precision. Characterization of the Dbx promoter and enhancer motifs will contribute to these developments. To date, few enhancers have been reported that direct temporally and spatially specific gene expression in the brain and none as yet are capable of directing regionally specific expression in the forebrain (Logan et al., 1993; Echelard et al., 1994) . The Dbx enhancer can be used in transgenic animals to direct ectopic expression of selected genes of interest as a means of deciphering the complex genetic control systems that regulate CNS development.
Experimental procedures
I. DNA constructs
All constructs used in this study were generated using standard molecular cloning techniques (Sambrook et al., 1989) . Incompatible ends of DNA fragments were rendered blunt by Klenow before ligation where necessary. The 5.7 kb-Lac Z reporter was constructed by inserting a 5.7 kb Kpn I-Bst E II Dbx genomic DNA fragment between the Kpn I and Bst E II sites of the plasmid phsp-Lac Z (gift of Dr. Janet Rossant) (Fig. 1) . This 5.7 kb genomic DNA fragment contains the partial 5' untranslated sequence, basal promoter and the upstream sequence. The 2.7 kb-Lac Z and 1.6 kb-Lac Z were constructed by inserting the 2.7 kb Not I-Bst E II and the 1.6 kb Hind III-Bst E II fragments between the KpnI and Bst E II sites of the plasmid phsp-Lac Z, respectively. As the result of Kpn I-Bst E II digestion of the plasmid phsp-Lac Z, the heat shock promoter was deleted from the original phsp-Lac Z. The promoter-less Lac Z gene is under the control of Dbx transcriptional unit in all the constructs described above. The 3 kb-hsplac Z and 3 kb-rhsplac Z were constructed by inserting the 3 kb Kpn I-Not I Dbx genomic DNA fragment into the KpnI site of the phspLac Z. The orientation of the 3 kb fragment in 3 kb-hsplac Z is the same as in the Dbx gene, while the orientation of the 3 kb fragment in 3 kb-rhsplac Z is opposite to that of the Dbx gene. The 3.5 kb-hsplac Z is a similar construct to 3 kbhspLac Z and contains a 3.5 kb Kpn I-Eco R I fragment upstream of hspLac Z. In 3 kb-hsplac Z, 3 kb-rhsplac Z and 3.5 kb-hsplac Z, the heat shock promoter of the plasmid phsp-Lac Z was retained and served as a basal promoter. Plasmid DNAs were routinely isolated by an alkaline lysis method followed by ultracentrifugation on a CsCl gradient (Sambrook et al., 1989) . Prior to injection, DNA fragments were excised from vector sequences by digesting with appropriate restriction enzymes and isolated by ultracentrifugation on a sucrose density gradient (Sambrook et al., 1989) . DNA fragments were dialyzed extensively against 10 mM Tris (pH 7.5) and 0.25 mM EDTA, and their concentration was adjusted to l-3 ,ug/ ml.
Generation of transgenic mice
Transgenic mice were generated by injecting DNA into pronuclei of fertilized oocytes of inbred FVB mice (Gordon and Ruddle, 1983) . Eggs that survived injection were transplanted into the oviduct of pseudopregnant CD-1 or B6/CBA Fl fosters. The founder generation embryos were analyzed for the expression of the transgene at 11.5 days p.c. Alternatively, some of the embryos were allowed to develop to term and transgene expression was analyzed in the Fl embryos obtained by timed mating. For staging embryos, the day the copulation plug was observed was considered to be 0.5 days p.c.
Southern blot analysis
Southern blot analysis was carried out as described (Sambrook et al., 1989) . Genomic DNA was isolated from placenta of embryo or tails of young mice, 4-5 weeks old as described (Hogan et al., 1986; Laird et al., 1991) . Genomic DNA (lOpug) was digested with restriction enzymes, electrophoresed on agarose gels and transferred to Hybond N filters (Amersham). The filters were hybridized with the probes (GEPl.11, Fig. 1 ; or 3.7 kb Hind III-Barn HI fragment from pCHll0, Pharmacia) which were labeled non-radioactively with 'Genius Nonradioactive Nucleic Acid Labeling and Detection Kit' (Boehringer-Mannheim).
The hybridized products were visualized by following the manufacturer's instructions.
Detection offl-gal activity
Embryos were dissected free from maternal tissues into cold phosphate buffered saline (PBS), fixed in 0.25% formaldehyde/O.1 M NaH2P04 (pH 7.4) for 30 min (for embryos of 10.5 days p.c. or younger) or 4% paraformaldehyde/O.l M NaHzPOa (pH 7.4) for 1 h (for embryos of 11.5 days p.c. or older) on ice, rinsed in 0.1 M NaH2P04 (pH 7.4) and incubated at 37°C for 4 h to overnight in staining solution containing 0.1 M NaH2P04 (pH 7.4), 2 mM MgCl*, 0.01% sodium deoxycholate, 0.02% NP-40, 5 mM potassium ferrocyanide, 4.5 mM potassium ferricyanide and 5 mg/ml X-gal. For embryos of 11.5 days p.c. and older, 1 mM potassium ferrocyanide and 0.9 mM potassium ferricyanide were used in the staining solution. Stained embryos were photographed using a Wild macroscope with Kodak T160 slide film. To detect /?-gal activity in embryo sections, embryos were fixed in PBS with 1% paraformaldehyde and 0.2% glutaraldehyde for 3-4 h on ice and frozen in OCT compound (Miles). Sections of lO-12pm were produced by a cryostat and applied to glass slides. The sections were rinsed in PBS three times for 5 min each at room temperature. Subsequently the sections were stained overnight at 37'C in the same staining solution as the whole mount embryos, and then counterstained briefly in nuclear fast red. After dehydration through graded ethanol, the slides were air-dried and mounted in Dpx (Fluka).
